The analysis of neurotoxicity at ASH 2017
Increased risk of myeloma in rescue workers exposed to smoke and toxins after 9/11
How is the landscape of Hodgkin lymphoma therapy changing?
Venetoclax resistance and alternative treatments in CLL
ADCT-402 - a drug to watch